Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on BG Medicine and Cardiome Pharma

Continue Reading

Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on American Electric Power and SCANA

Continue Reading

Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Eli Lilly and McDonald-s

Continue Reading

Special Dividend Payments Increase Fourfold in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase

Five Star Equities Provides Stock Research on Kimberly Clark and Xerox

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Infinity Pharmaceuticals and Vertex Pharmaceuticals

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on Lorillard and Nucor

Continue Reading

Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Altria Group and Johnson & Johnson

Continue Reading

Dividend Investors Set to Face Major Dividend Tax Increase in 2013

Five Star Equities Provides Stock Research on American Capital Agency and Annaly Capital

Continue Reading

End of Dividend Top Tax Rate of 15% a Major Concern for Dividend Investors in the New Year

Five Star Equities Provides Stock Research on Invesco and Two Harbors Investment

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Athersys and Santarus

Continue Reading